FDA advisers back Pfizer’s COVID-19 vaccine for young kids
By LAURAN NEERGAARD and MATTHEW PERRONE Associated Press WASHINGTON (AP) — U.S. health advisers have endorsed kid-size doses of Pfizer’s COVID-19 vaccine for younger children. The vote Tuesday by the Food and Drug Administration panel moves the U.S. closer to vaccinating children ages 5 to 11. The FDA isn’t bound by the panel’s recommendation and
Continue Reading